Synaptogenix Inc (SNPX)

[Cyosol]

Here's what I got from the presentation so far:

- Dr. Alkon mentioning Bryostatin possibly treating Parkinson's too (besides Alzheimer's, Fragile X, Niemann-Pick Type C, Rett, Stroke, TBI etc.)

- Dr. Ryan mentioning the Fragile X collaboration costing about $300,000

- Dr. Ryan talking about how more work needs to be done to educate the market and how Biogen seeing a $10 billion market cap increase is something they hope to see for Neurotrope too

- Dr. Ryan acknowledging that releasing the top-line data last year was a mistake and that they should have waited for the full data before making an announcement. They intend to learn from this experience and not rush out data after the next trial.

- They can and expect to do more than just one dosing cycle for patients in the future

- Synthesis of Bryostatin is very affordable due to how small the doses are, which means you don't need to produce a lot of the stuff